Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug

Diabetologia

Volumn 46, Issue 9, 2003, Pages 1269-1275

  Gardiner, T A ^a   Anderson, H R ^a   Degenhardt, T ^b   Thorpe, S R ^b   Baynes, J W ^b,c   Archer, D B ^a   Stitt, A W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetic retinopathy; Stereology; Sulindac

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALLOXAN; ANTIOXIDANT; COLLAGEN; INOSITOL; MALONALDEHYDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOSIDINE; POLYOL; SORBITOL; STREPTOZOCIN; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CAPILLARY BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOG; DOSE RESPONSE; DRUG EFFECT; ERYTHROCYTE; HYPERGLYCEMIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RETINA BLOOD VESSEL; RETINA CAPILLARY; SKIN; STATISTICAL SIGNIFICANCE; STEREOLOGY; THICKNESS; VASCULAR DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; DOGS; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; MICROSCOPY, ELECTRON; REFERENCE VALUES; RETINAL VESSELS; SKIN; SULINDAC;

EID: 0141483046     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1147-z     Document Type: Article

References (41)

1. DCCT Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329:977-986
2. Spranger J, Pfeiffer AF (2001) New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 109:S438-S450
3. Bobbink IW, Boer HC de, Tekelenburg WL, Banga JD, Groot PG de (1997) Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: involvement of vitronectin. Diabetes 46:87-93
4. Kalfa TA, Gerritsen ME, Carlson EC, Binstock AJ, Tsilibary EC (1995) Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci 36:2358-2367
5. Anderson HR, Stitt AW, Gardiner TA, Archer DB (1995) Diabetic retinopathy: morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environments. Br J Ophthalmol 79:1120-1123
6. Stitt AW, Anderson HR, Gardiner TA, Archer DB (1994) Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Ophthalmol 78:133-137
7. Engerman RL, Kern TS, Garment MB (1993) Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition. J Diabetes Complications 7:241-245
8. Robison WG Jr, Nagata M, Kinoshita JH (1988) Aldose reductase and retinal capillary basement membrane thickening. Exp Eye Res 46:343-348
9. Mansour SZ, Hatchell DL, Chandler D, Saloupis P, Hatchell MC (1990) Reduction of basement membrane thickening in diabetic cat retina by sulindac. Invest Ophthalmol Vis Sci 31:457-463
10. Tugwell P, Ludwin D, Gent M et al. (1997) Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs. J Rheumatol 24:1122-1125
11. Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM (2002) Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122:641-645
12. Jacobson M, Sharma YR, Cotlier E, Hollander JD (1983) Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors. Invest Ophthalmol Vis Sci 24:1426-1429
13. Crabbe MJ, Freeman G, Halder AB, Bron AJ (1985) The inhibition of bovine lens aldose reductase by Clinoril, its absorption into the human red cell and its effect on human red cell aldose reductase activity. Ophthalmic Res 17:85-89
14. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16:438-440
15. Kern TS, Engerman RL (2001) Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50:1636-1642
16. Anderson HR, Stitt AW, Gardiner TA, Lloyd SJ, Archer DB (1993) Induction of alloxan/streptozotocin diabetes in dogs: a revised experimental technique. Lab Anim 27:281-285
17. Anderson HR, Stitt AW, Gardiner TA, Archer DB (1994) Estimation of the surface area and volume of the retinal capillary basement membrane using the stereologic method of vertical sections. Anal Quant Cytol Histol 16:253-260
18. Baddeley AJ, Gundersen HJ, Cruz-Orive LM (1986) Estimation of surface area from vertical sections. J Microsc 142:259-276
19. Young IS, Trimble ER (1991) Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 28:504-508
20. Catignani GL, Bieri JG (1983) Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem 29:708-712
21. Chapple IL, Mason GI, Garner I, Matthews JB, Thorpe GH, Maxwell SR, Whitehead TP (1997) Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 34:412-421
22. Booth BP, Bennett BM, Brien JF, Elliott DA, Marks GS, McCans JL, Nakatsu K (1990) Assay of glyceryl trinitrate, isosorbide dinitrate, and their metabolites in plasma by large-bore capillary column gas-liquid chromatography. Biopharm Drug Dispos 11:663-677
23. Gremeau I, Sautou V, Pinon V, Rivault F, Chopineau J (1995) Solid-phase extraction of isosorbide dinitrate and two of its metabolites from plasma for gas chromatographic analysis. J Chromatogr B Biomed Appl 665:399-403
24. Dyer DG, Dunn JA, Thorpe SR, Bailie KE, Lyons TJ, McCance DR, Baynes JW (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469
25. Dunn JA, McCance DR, Thorpe SR, Lyons TJ, Baynes JW (1991) Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 30:1205-1210
26. Stegemann H, Stalder K (1967) Determination of hydroxyproline. Clin Chim Acta 18:267-273
27. Robison WG, Jr., Kador PF, Akagi Y, Kinoshita JH, Gonzalez R, Dvornik D (1986) Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes 35:295-299
28. Kern TS, Engerman RL (1991) Retinal polyol and myoinositol in galactosemic dogs given an aldose-reductase inhibitor. Invest Ophthalmol Vis Sci 32:3175-3177
29. Engerman RL, Kern TS (1993) Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 42:820-825
30. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH (1990) Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol 108:1301-1309
31. Stitt A, Gardiner TA, Alderson NL et al. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826-2832
32. Stitt AW, Jenkins AJ, Cooper ME (2002) Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 11:1205-1223
33. Degenhardt TP, Fu MX, Voss E et al. (1999) Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats. Diabetes Res Clin Pract 43:81-89
34. Cefalu WT, Bell-Farrow AD, Wang ZQ, Sonntag WE, Fu MX, Baynes JW, Thorpe SR (1995) Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen. J Gerontol A Biol Sci Med Sci 50:B337-B341
35. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR (1996) The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982-9986
36. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW (1997) N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565-570
37. McLellan AC, Phillips SA, Thornalley PJ (1992) The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 206:17-23
38. Nishikawa T, Edelstein D, Du XL et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790
39. Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-9
40. Kowluru RA, Kern TS, Engerman RL, Armstrong D (1996) Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 45:1233-1237
41. Armstrong D, al-Awadi F (1991) Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med 11:433-436